ALNY : Alnylam Pharmaceuticals stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2026-03-04 |
|---|---|---|---|---|
| 2026 | $253.99 | $216.41 | $317.36 | -22.4% |
| 2027 | $228.91 | $194.95 | $274.58 | -30.06% |
| 2028 | $172.0 | $137.03 | $194.79 | -47.45% |
| 2029 | $168.82 | $138.32 | $201.03 | -48.42% |
| 2030 | $144.16 | $136.33 | $152.69 | -55.96% |
| 2031 | $135.1 | $127.45 | $146.94 | -58.72% |
| 2032 | $128.3 | $126.18 | $130.42 | -60.8% |
| 2033 | $125.16 | $123.0 | $129.31 | -61.76% |
| 2034 | $124.66 | $121.83 | $126.28 | -61.91% |
| 2035 | $122.49 | $121.24 | $123.67 | -62.58% |
| 2036 | $120.71 | $120.29 | $121.23 | -63.12% |
The 14 Wall Street analysts offering Alnylam Pharmaceuticals stock forecast in the last 6 months have average price target of
$516.72 with a high forecast of $570.0 and a low forecast of $470.0.
The average Alnylam Pharmaceuticals stock forecast represents a 57.87%
increase from the last price of $327.299987792969.
For Alnylam Pharmaceuticals stock forecast for 2026, 9 predictions are offered for each month of 2026 with average Alnylam Pharmaceuticals stock
forecast of $253.99, a high forecast of $317.36, and a low forecast of $216.41.
The average Alnylam Pharmaceuticals stock forecast 2026 represents a -22.4%
decrease from the last price of $327.299987792969.
For Alnylam Pharmaceuticals stock forecast for 2027, 12 predictions are offered for each month of 2027 with average Alnylam Pharmaceuticals stock
forecast of $228.91, a high forecast of $274.58, and a low forecast of $194.95.
The average Alnylam Pharmaceuticals stock forecast 2027 represents a -30.06%
decrease from the last price of $327.299987792969.
For Alnylam Pharmaceuticals stock forecast for 2029, 12 predictions are offered for each month of 2029 with average Alnylam Pharmaceuticals stock
forecast of $168.82, a high forecast of $201.03, and a low forecast of $138.32.
The average Alnylam Pharmaceuticals stock forecast 2029 represents a -48.42%
decrease from the last price of $327.299987792969.
For Alnylam Pharmaceuticals stock forecast for 2031 (5 year), 12 predictions are offered for each month of 2031 with average Alnylam Pharmaceuticals stock
forecast of $135.1, a high forecast of $146.94, and a low forecast of $127.45.
The average Alnylam Pharmaceuticals stock forecast 2031 represents a -58.72%
decrease from the last price of $327.299987792969.
For Alnylam Pharmaceuticals stock forecast 2032, 12 predictions are offered for each month of 2032 with average Alnylam Pharmaceuticals stock
forecast of $128.3, a high forecast of $130.42, and a low forecast of $126.18.
The average Alnylam Pharmaceuticals stock forecast 2032 represents a -60.8%
decrease from the last price of $327.299987792969.
For Alnylam Pharmaceuticals stock forecast for 2036 (10 year), 3 predictions are offered for each month of 2036 with average Alnylam Pharmaceuticals stock
forecast of $120.71, a high forecast of $121.23, and a low forecast of $120.29.
The average Alnylam Pharmaceuticals stock forecast 2036 represents a -63.12%
decrease from the last price of $327.299987792969.
Please, see more forecasts below.
ALNY : Alnylam Pharmaceuticals stock forecast by Wall Street Analysts
The average Alnylam Pharmaceuticals stock forecast from last 6 month is $516.72, and this show a 13.32% increase in average from the prior price target of the each prediction. Also, this average forecast of $516.72 represents a 32.08% increase from the past average forecast of $391.23, 6 months ago from 43 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-10-31 | Barclays | $460.00 | $527.0000 | Overweight |
| 2025-10-31 | Piper Sandler | $449.00 | $489 | Overweight |
| 2025-10-30 | Jefferies | $550.00 | $549.0000 | Buy |
| 2025-10-17 | Truist Securities | $459.0000 | $535.0000 | Buy |
| 2025-10-13 | JP Morgan | $475.00 | $473.0000 | Overweight |
| 2025-10-10 | HC Wainwright & Co. | $570.0000 | $570.0000 | Buy |
| 2025-10-06 | Stifel | $441.0000 | $495.0000 | Buy |
| 2025-10-06 | Morgan Stanley | $405.00 | $475.0000 | Equal-Weight |
| 2025-09-19 | RBC Capital | $435.0000 | $500.0000 | Outperform |
| 2025-09-17 | B of A Securities | $453.0000 | $520 | Buy |
| 2025-09-16 | Goldman Sachs | $504.0000 | $566 | Buy |
| 2025-09-15 | Jefferies | $453.0000 | $550.0000 | Buy |
| 2025-09-11 | Evercore ISI Group | $280.0000 | $515.0500 | Outperform |
| 2025-09-08 | BMO Capital | $450.0000 | $470 | Outperform |
| 2025-09-02 | Citigroup | $527.0000 | $583.0000 | Buy |
| 2025-09-02 | HC Wainwright & Co. | $570.0000 | $570.0000 | Buy |
| 2025-08-07 | HC Wainwright & Co. | $500.0000 | $570.0000 | Buy |
| 2025-08-06 | JP Morgan | $348.00 | $475.0000 | Overweight |
| 2025-08-04 | Wolfe Research | Peer Perform | ||
| 2025-08-04 | Oppenheimer | $490 | Outperform | |
| 2025-08-01 | UBS | $403.0000 | $550.0000 | Buy |
| 2025-08-01 | Morgan Stanley | $312.0000 | $405 | Equal-Weight |
| 2025-08-01 | Chardan Capital | $325.00 | $400 | Buy |
| 2025-08-01 | Piper Sandler | $304.0000 | $449 | Overweight |
| 2025-08-01 | Barclays | $329.00 | $460.0000 | Overweight |
| 2025-08-01 | Raymond James | $370.0000 | $424 | Outperform |
| 2025-08-01 | Wells Fargo | $333.00 | $395.0000 | Equal-Weight |
| 2025-08-01 | Canaccord Genuity | $390.00 | $415.0000 | Buy |
| 2025-08-01 | Scotiabank | $342.00 | $450.0000 | Sector Outperform |
| 2025-07-31 | Needham | $377.0000 | $478.0000 | Buy |
| 2025-07-29 | Raymond James | $308.0000 | $370.0000 | Outperform |
| 2025-07-21 | Truist Securities | $385.0000 | Buy | |
| 2025-07-16 | JP Morgan | $338.00 | $348.0000 | Overweight |
| 2025-07-11 | B of A Securities | $336 | $359.0000 | Buy |
| 2025-07-11 | Citigroup | $364.0000 | $404.0000 | Buy |
| 2025-07-07 | Jefferies | $328.0000 | $384.0000 | Buy |
| 2025-06-30 | Wells Fargo | $287.00 | $333.0000 | Equal-Weight |
| 2025-06-26 | Needham | $320 | $377.0000 | Buy |
| 2025-06-24 | BMO Capital | $300.0000 | $360.0000 | Outperform |
| 2025-06-12 | JP Morgan | $330.0000 | $338.0000 | Overweight |
| 2025-05-02 | Chardan Capital | $300.00 | $325 | Buy |
| 2025-05-02 | UBS | $331.0000 | $349.0000 | Buy |
| 2025-04-11 | Morgan Stanley | $284.00 | $268 | Equal-Weight |
| 2025-04-09 | Needham | $320.00 | $320 | Buy |
| 2025-04-02 | HC Wainwright & Co. | $500.0000 | $500 | Buy |
| 2025-03-31 | Stifel | $300.0000 | $345 | Buy |
| 2025-03-31 | Redburn Atlantic | $353.0000 | Buy | |
| 2025-03-31 | Scotiabank | $338.00 | $342.0000 | Sector Outperform |
| 2025-03-24 | JP Morgan | $280.00 | $328.0000 | Overweight |
| 2025-03-21 | Citigroup | $338.0000 | $351.0000 | Buy |
| 2025-03-21 | Canaccord Genuity | $385.00 | $390.0000 | Buy |
| 2025-03-21 | RBC Capital | $310.0000 | $330.0000 | Outperform |
| 2025-03-21 | Scotiabank | $300.00 | $338 | Sector Outperform |
| 2025-03-21 | Wells Fargo | $275.0000 | $287.0000 | Equal-Weight |
| 2025-03-21 | B of A Securities | $302.0000 | $325 | Buy |
| 2025-03-21 | Chardan Capital | $300.00 | $300.00 | Buy |
| 2025-03-21 | Needham | $320.0000 | $320 | Buy |
| 2025-03-11 | JP Morgan | $272.0000 | $280.0000 | Neutral |
Alnylam Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2026-03-06 | $330.70 | 1.04% |
| 2026-03-09 | $340.32 | 2.91% |
| 2026-03-10 | $338.53 | -0.52% |
| 2026-03-11 | $343.25 | 1.39% |
| 2026-03-12 | $355.58 | 3.59% |
ALNY : Long term Alnylam Pharmaceuticals stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2026 Apr. is $317.36 , for 2027 Mar. is $256.92 , for 2030 Mar. is $136.98 , for 2031 Mar. is $142.22 , for 2035 Mar. is $121.37 , and for 2036 Mar. is $120.29.
ALNY : Alnylam Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Apr. | $317.36 | -3.04% |
| 2026 May. | $285.07 | -10.18% |
| 2026 Jun. | $250.11 | -12.26% |
| 2026 Jul. | $225.13 | -9.99% |
| 2026 Aug. | $216.41 | -3.87% |
| 2026 Sep. | $223.14 | 3.11% |
| 2026 Oct. | $237.59 | 6.47% |
| 2026 Nov. | $257.78 | 8.50% |
| 2026 Dec. | $273.29 | 6.02% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $274.58 | 0.47% |
| 2027 Feb. | $265.37 | -3.35% |
| 2027 Mar. | $256.92 | -3.18% |
| 2027 Apr. | $246.95 | -3.88% |
| 2027 May. | $236.40 | -4.27% |
| 2027 Jun. | $226.54 | -4.17% |
| 2027 Jul. | $218.43 | -3.58% |
| 2027 Aug. | $212.72 | -2.61% |
| 2027 Sep. | $208.75 | -1.87% |
| 2027 Oct. | $204.92 | -1.83% |
| 2027 Nov. | $200.41 | -2.20% |
| 2027 Dec. | $194.95 | -2.72% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $190.36 | -2.35% |
| 2028 Feb. | $189.22 | -0.60% |
| 2028 Mar. | $191.78 | 1.36% |
| 2028 Apr. | $194.79 | 1.57% |
| 2028 May. | $192.48 | -1.18% |
| 2028 Jun. | $186.17 | -3.28% |
| 2028 Jul. | $175.96 | -5.49% |
| 2028 Aug. | $164.88 | -6.29% |
| 2028 Sep. | $154.53 | -6.28% |
| 2028 Oct. | $137.10 | -11.28% |
| 2028 Nov. | $137.03 | -0.06% |
| 2028 Dec. | $149.73 | 9.27% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $164.80 | 10.06% |
| 2029 Feb. | $175.65 | 6.58% |
| 2029 Mar. | $177.73 | 1.18% |
| 2029 Apr. | $173.57 | -2.34% |
| 2029 May. | $173.36 | -0.12% |
| 2029 Jun. | $193.34 | 11.53% |
| 2029 Jul. | $201.03 | 3.98% |
| 2029 Aug. | $179.15 | -10.89% |
| 2029 Sep. | $159.66 | -10.88% |
| 2029 Oct. | $147.76 | -7.46% |
| 2029 Nov. | $141.49 | -4.24% |
| 2029 Dec. | $138.32 | -2.24% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $136.89 | -1.03% |
| 2030 Feb. | $136.33 | -0.41% |
| 2030 Mar. | $136.98 | 0.47% |
| 2030 Apr. | $138.40 | 1.03% |
| 2030 May. | $139.96 | 1.13% |
| 2030 Jun. | $141.83 | 1.34% |
| 2030 Jul. | $145.06 | 2.28% |
| 2030 Aug. | $148.85 | 2.61% |
| 2030 Sep. | $151.73 | 1.94% |
| 2030 Oct. | $152.69 | 0.63% |
| 2030 Nov. | $151.70 | -0.65% |
| 2030 Dec. | $149.46 | -1.48% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $146.94 | -1.68% |
| 2031 Feb. | $144.55 | -1.63% |
| 2031 Mar. | $142.22 | -1.61% |
| 2031 Apr. | $139.89 | -1.64% |
| 2031 May. | $137.54 | -1.68% |
| 2031 Jun. | $135.03 | -1.82% |
| 2031 Jul. | $132.43 | -1.92% |
| 2031 Aug. | $130.21 | -1.68% |
| 2031 Sep. | $128.84 | -1.06% |
| 2031 Oct. | $128.23 | -0.47% |
| 2031 Nov. | $127.83 | -0.31% |
| 2031 Dec. | $127.45 | -0.30% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $127.11 | -0.27% |
| 2032 Feb. | $126.50 | -0.48% |
| 2032 Mar. | $126.18 | -0.26% |
| 2032 Apr. | $126.26 | 0.06% |
| 2032 May. | $126.74 | 0.38% |
| 2032 Jun. | $127.63 | 0.70% |
| 2032 Jul. | $128.68 | 0.82% |
| 2032 Aug. | $129.58 | 0.70% |
| 2032 Sep. | $130.18 | 0.46% |
| 2032 Oct. | $130.42 | 0.19% |
| 2032 Nov. | $130.33 | -0.07% |
| 2032 Dec. | $129.95 | -0.29% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $129.31 | -0.49% |
| 2033 Feb. | $128.41 | -0.70% |
| 2033 Mar. | $127.39 | -0.80% |
| 2033 Apr. | $126.35 | -0.82% |
| 2033 May. | $125.34 | -0.79% |
| 2033 Jun. | $124.47 | -0.70% |
| 2033 Jul. | $123.76 | -0.57% |
| 2033 Aug. | $123.24 | -0.41% |
| 2033 Sep. | $123.00 | -0.20% |
| 2033 Oct. | $123.07 | 0.05% |
| 2033 Nov. | $123.45 | 0.31% |
| 2033 Dec. | $124.08 | 0.52% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $124.85 | 0.62% |
| 2034 Feb. | $125.60 | 0.60% |
| 2034 Mar. | $126.10 | 0.40% |
| 2034 Apr. | $126.28 | 0.14% |
| 2034 May. | $126.14 | -0.11% |
| 2034 Jun. | $125.78 | -0.29% |
| 2034 Jul. | $125.27 | -0.41% |
| 2034 Aug. | $124.62 | -0.52% |
| 2034 Sep. | $123.88 | -0.59% |
| 2034 Oct. | $123.12 | -0.61% |
| 2034 Nov. | $122.43 | -0.56% |
| 2034 Dec. | $121.83 | -0.50% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $121.41 | -0.34% |
| 2035 Feb. | $121.24 | -0.14% |
| 2035 Mar. | $121.37 | 0.11% |
| 2035 Apr. | $121.79 | 0.35% |
| 2035 May. | $122.41 | 0.51% |
| 2035 Jun. | $123.04 | 0.51% |
| 2035 Jul. | $123.50 | 0.37% |
| 2035 Aug. | $123.67 | 0.14% |
| 2035 Sep. | $123.59 | -0.06% |
| 2035 Oct. | $123.24 | -0.29% |
| 2035 Nov. | $122.67 | -0.46% |
| 2035 Dec. | $121.97 | -0.57% |
ALNY : Alnylam Pharmaceuticals stock forecast for 2036
| Date | Price Target | Change |
|---|---|---|
| 2036 Jan. | $121.23 | -0.60% |
| 2036 Feb. | $120.62 | -0.51% |
| 2036 Mar. | $120.29 | -0.27% |
Financial Data for Alnylam Pharmaceuticals stock
Frequently Asked Questions about Alnylam Pharmaceuticals stock forecast
Is Alnylam Pharmaceuticals a good long term stock?
From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2026 Apr. is $317.361951037371 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2027 Mar. is $256.924162090318 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2030 Mar. is $136.980830208527 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2031 Mar. is $142.221062607578 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2035 Mar. is $121.365997314474 From Alnylam Pharmaceuticals stock forecast , Alnylam Pharmaceuticals (ALNY) stock cannot be a good investment choice. According to AIPickup, the Alnylam Pharmaceuticals stock price forecast for 2036 Mar. is $120.28675831247
Is Alnylam Pharmaceuticals stock overvalued?
Alnylam Pharmaceuticals (ALNY) stock is expected to go DOWN . Therefore, AIPickup would say that Alnylam Pharmaceuticals (ALNY) stock is overvalued.
Will Alnylam Pharmaceuticals stock price go up?
No. The Alnylam Pharmaceuticals stock price forecast for 2027 Mar. is $256.924162090318
Is Alnylam Pharmaceuticals stock a good buy now?
Since closing price on 2026-03-04 is $327.299987792969 and forecast for 2027 Mar. is $256.92, Alnylam Pharmaceuticals stock is not a good 1 year investment.
14 Days Historical Data for Alnylam Pharmaceuticals stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| ALNY stock price for 2026-02-12 | $308.48 | $314.42 | $298.00 | $315.51 |
| ALNY stock price for 2026-02-13 | $314.40 | $302.55 | $302.55 | $318.44 |
| ALNY stock price for 2026-02-17 | $332.61 | $316.80 | $315.63 | $336.21 |
| ALNY stock price for 2026-02-18 | $332.68 | $328.86 | $324.53 | $335.80 |
| ALNY stock price for 2026-02-19 | $339.37 | $332.24 | $326.33 | $339.61 |
| ALNY stock price for 2026-02-20 | $336.19 | $336.58 | $335.83 | $345.90 |
| ALNY stock price for 2026-02-23 | $329.35 | $335.73 | $326.76 | $341.39 |
| ALNY stock price for 2026-02-24 | $332.85 | $328.22 | $324.48 | $333.07 |
| ALNY stock price for 2026-02-25 | $327.36 | $332.76 | $325.24 | $334.42 |
| ALNY stock price for 2026-02-26 | $331.24 | $328.67 | $322.00 | $333.47 |
| ALNY stock price for 2026-02-27 | $332.92 | $331.24 | $328.39 | $334.80 |
| ALNY stock price for 2026-03-02 | $325.07 | $329.41 | $323.16 | $334.42 |
| ALNY stock price for 2026-03-03 | $318.65 | $321.37 | $315.20 | $324.06 |
| ALNY stock price for 2026-03-04 | $327.30 | $319.20 | $317.25 | $327.96 |